Frank Greenway, MD, FOMA
PresidentDr. Frank Greenway directs outpatient research with a focus on obesity at the Pennington Biomedical Research Center. He graduated from Stanford University, obtained his medical degree from the UCLA, did his internal medicine and endocrinology training at Harbor-UCLA, and holds board certification in internal medicine and endocrinology. Dr. Greenway practiced internal medicine and endocrinology and taught at Harbor-UCLA for 20 years before coming to Pennington as a professor. He has published more than 200 articles and holds several patents. He has an interest in developing new treatments for obesity, including drugs, dietary supplements, medical foods and devices.
Richard Lindquist, MD, FAASP, FOMA
Vice PresidentDr. Richard (Rick) Lindquist is the Director of Medical Weight Management at Swedish Health Services and the Director of Medical Weight Management at Providence St. Joseph Health Services in Seattle. He is also a consultant working with hospitals and health systems around the county that want to add complementary medical weight management services to their already successful bariatric surgery programs. Dr. Lindquist is one of the founders of Monarch Medical Weight Loss Centers in Oregon. He is board certified in family medicine with a background in emergency medicine and emergency medical services (EMS). He is also a Diplomate of the American Board of Obesity Medicine and a Fellow of the Obesity Medicine Association. In 2001, Dr. Lindquist was recognized as the Oregon EMS Medical Director of the Year. His experience in EMS and community service continues to inform his activities in program development, community and physician education, practitioner training, and direct patient care. Dr. Lindquist received his medical degree from the University of Washington in Seattle and completed his residency at the University of South Florida in Tampa, Fla.
Suzanne Cuda, MD, FOMA
Amy Ingersoll, PA-C
DirectorAmy Ingersoll is the program director at Arizona Health & Wellness. Amy approaches obesity medicine with a passion, offering a better quality of life and a healthy lifestyle that includes education focused on medicine, behavior, exercise, and nutrition. Amy understands that chronic weight management and successful obesity treatment is a combination of all four facets, and all four are necessary for long-term success.
Amy spent a large portion of her childhood living aboard a small sailing boat with her family on the island of Guam, where her love of medicine and caring for others flourished. She graduated Suma Cum Laude from Southwest Minnesota State University and continued her medical education at Midwestern University in Glendale, Arizona, where she received her credentials: Master’s of Medical Science, PA-C. Amy has been treating patients in the greater Phoenix since 2009 and is passionate about obesity and chronic weight management treatment with her patients.
Beyond the office, Amy is an active member of the Obesity Medicine Association. She has spoken nationally at conferences on obesity medicine. Amy is a part of her national organization, AAPA's, 3-year Obesity Initiative on their Educational Advisory Board. She serves on the Commission on Dietetic Registration’s Exam Writing Committee for the upcoming multi-disciplinary obesity certification exam. Amy is adjunct faculty at two of her local PA programs where she guest lectures on obesity medicine. She is a clinical preceptor and helps to continue education of future PAs. Amy is passionate about not only furthering obesity education and treatment in her own patient population, but also in furthering the education of healthcare providers in understanding obesity as a disease.
Scott Kahan, MD, MPH
DirectorDr. Scott Kahan is the medical director of Strategies to Overcome and Prevent (STOP) Obesity Alliance and director of the National Center for Weight and Wellness in Washington, D.C. He serves on the faculty of the Johns Hopkins Bloomberg School of Public Health and the George Washington University Schools of Medicine and Public Health. He also serves on board of directors of American Board of Obesity Medicine and the Obesity Treatment Foundation.
Wickham Simonds, MD, FOMA
DirectorDr. Simonds is the founder of Dr. Simonds Metabolics & Weight Loss and currently practices obesity medicine with offices in Durham and Raleigh. Dr. Simonds is board-certified by the American Board of Emergency Medicine and is a diplomate of the American Board of Obesity Medicine. He was chief resident during his residency in emergency medicine at Penn State University/York Hospital. Dr. Simonds received his MD from East Carolina University after graduating Summa Cum Laude with a BS in biology from Campbell University.
He was raised in Durham, N.C., and he has served his country in the U.S. Army with duty stations in Korea, Louisiana, and Iraq. The latter involved deployments in (1) 1990 and 1991 for Operation Desert Shield and Storm, (2) 2003 to Southern Iraq in support of Operation Enduring and Iraqi Freedom, and (3) 2005 to Iraq in support of Operation Iraqi Freedom.
Eric C. Westman, MD, MHS, MFOMA
DirectorDr. Eric C. Westman is an associate professor of medicine and the director of the Lifestyle Medicine Clinic at Duke University Health System. Dr. Westman is board certified in internal medicine and obesity medicine, and is a past-president of the Obesity Medicine Association. Dr. Westman received his medical degree from the University of Wisconsin Madison, completed his internal medicine residency at the University of Kentucky, and received a master’s degree in biostatistics during a general medicine fellowship at Duke University Medical Center. His clinical and research expertise relates to low carbohydrate, "Keto", diets, having published over 45 peer-reviewed publications on this topic. He teaches regularly at OMA conferences, and is the course coordinator for one of the nation's only medical school electives relating to obesity management: Duke Med 415C. He is author of the New York Times Bestseller The New Atkins for a New You, and receives royalties from the books Keto Clarity and Cholesterol Clarity. He is founder of HEAL Clinics and Adapt Your Life, companies based on the low carbohydrate diet approach.
Evan Berk, PhD
Member at LargeEvan is currently the Global R&D Lead for Metabolic Health at Nestle Health Science. He is responsible for the development and delivery of the innovation pipeline for products related to obesity care and diabetes management. Evan has over 10 years of R&D experience in the pharmaceutical and consumer healthcare industry across a variety of therapeutic areas. He currently serves as an adjunct faculty member in the Nutrition Department of Teacher’s College, Columbia University. He received his B.S. in Nutrition Science from Cornell University and Ph.D. from Columbia University in Human Nutrition.
Ted Kyle, RPh, MBA
Member at LargeTed Kyle, RPh, MBA, founded ConscienHealth in 2009. Ted is a pharmacist and healthcare innovation professional who works with health and obesity experts for sound policy and innovation to address obesity. In addition to his service to the Obesity Treatment Foundation, Ted serves on the Board of Directors for the Obesity Action Coalition, advises The Obesity Society on advocacy, and consults with organizations addressing the needs of people living with obesity. His widely-read daily commentary, published at ConscienHealth.org, reaches an audience of more than 10,000 thought leaders in health and obesity.
Member at Large
Ed Hendricks MD, MFOMA
Ex OfficioDr. Ed Hendricks graduated from Rice University, obtained his MD degree at Columbia University, College of Physicians and Surgeons, then served 2 years in internal medicine training at University of Texas, Parkland Hospital, followed by pathology residency at the University of Minnesota. He practiced pathology for 22 years before switching to Obesity Medicine. His solo Obesity Medicine private practice operates offices in Sacramento and Roseville, California. He has been a member of the ASBP/OMA since 1989, and since 2000 has served as Trustee of ABBM, predecessor of ABOM, then the ASBP, and currently the OTF. He is a Master Fellow of the OMA. He has published research on how physicians use antiobesity medicines, on effective use of long-term phentermine in obesity treatment, and two addiction medicine studies that strongly suggest phentermine has zero addiction potential. He served on the FDA Endocrinologic and Metabolic Advisory Committee, the committee that advises the FDA on drugs for obesity, diabetes and other endocrine diseases. His period of service, from 2010 through 2015, occurred during the years when the FDA considered and approved Qsymia, Contrave, Belviq, and Saxenda (voting for approval of each) and the meetings that considered large-scale, long-term cardiovascular outcome trials for all new obesity drugs.